Narrow Results Clear All
- Communication Improvement 1
- Culture of Safety 1
- Education and Training 1
- Error Reporting and Analysis 3
Legal and Policy Approaches
- Quality Improvement Strategies 4
Search results for "Regulation"
Rozovsky FA, Woods JR Jr, eds. San Francisco, CA: Jossey Bass; 2011. ISBN: 9781118086995.
This well-referenced and up-to-date handbook covers many of the regulatory and operational issues relevant to developing an organizational patient safety program. It is particularly strong in the areas of regulatory compliance, error reporting, and disclosure. Patient safety officers and risk managers are likely to find it of considerable interest.
Washington, DC: Office of Disease Prevention and Health Promotion, United States Department of Health and Human Services; September 2014.
This national action plan aims to align the efforts of multiple federal programs committed to reducing patient harms related to adverse drug events. The three initial high-priority targets of the action plan are anticoagulants, diabetes agents, and opioids. These medication classes were chosen due to their common usage and their very high potential to cause clinically significant, preventable, and measurable adverse events. The action plan outlines a four-pronged approach: surveillance, prevention, incentives and oversight, and research. The full report delves into detailed tactics for each of these areas, as well as for the three drug classes. Focusing on specific high-risk drug classes, rather than pursuing the commonly advocated approach of universal drug safety, was also recommended by a recent systematic review of medication errors.
London, UK: National Patient Safety Agency; 2007. ISBN: 9780955634093.
This report shares the results of the British National Patient Safety Agency effort to reduce medical error and found that safety wasn't always given the priority necessary to drive change and that data collection efforts could still be improved.
Washington, DC: United States Government Accountability Office; June 2006. Publication GAO-06-416.
This government report found that the clinical laboratory survey process is flawed, allowing safety requirements to be bypassed.
Amori G. Chicago, IL: American Society for Healthcare Risk Management; 2006.
This booklet shares scenarios and strategies for effective communication during disclosure of adverse events.
Nursing Homes: Despite Increased Oversight, Challenges Remain in Ensuring High-Quality Care and Resident Safety.
Washington, DC: United States Government Accountability Office; 2005. Report No. GAO-06-117.
This report shares findings from a 5-year review of nursing home quality and safety, which revealed inconsistencies in state surveys that affect the government's ability to adequately address problems in care.